Stengone Carmine N.
CIK 1861519
Transactions on file
9
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-08 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Sale | 2,500 | $41.1K | -30.1% | open → |
| 2026-09-08 | 2026-09-08 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Exer. | 2,500 | $2.5K | +1038.6% | open → |
| 2026-08-03 | 2026-08-03 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Sale | 2,500 | $40.0K | -28.2% | open → |
| 2026-08-03 | 2026-08-03 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Exer. | 2,500 | $2.5K | +1038.6% | open → |
| 2026-07-08 | 2026-07-08 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Sale | 2,500 | $40.0K | -28.1% | open → |
| 2026-07-08 | 2026-07-08 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Exer. | 2,500 | $2.5K | +1038.6% | open → |
| 2026-07-01 | 2026-06-30 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Sale | 10,000 | $160.1K | -28.2% | open → |
| 2026-07-01 | 2026-06-30 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Exer. | 2,500 | $3.1K | +812.7% | open → |
| 2026-07-01 | 2026-06-30 | CTNM Contineum Therapeutics, Inc. | OfficerDirector CEO and President | Exer. | 7,500 | $7.6K | +1038.6% | open → |
